Responses
Clinical and epidemiological research
Extended report
Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials
Compose a Response to This Article
Other responses
No responses have been published for this article.